JPS5919117B2 - ビンブラスチン・ロイロシジンおよびロイロクリスチン誘導体の製法 - Google Patents

ビンブラスチン・ロイロシジンおよびロイロクリスチン誘導体の製法

Info

Publication number
JPS5919117B2
JPS5919117B2 JP49037765A JP3776574A JPS5919117B2 JP S5919117 B2 JPS5919117 B2 JP S5919117B2 JP 49037765 A JP49037765 A JP 49037765A JP 3776574 A JP3776574 A JP 3776574A JP S5919117 B2 JPS5919117 B2 JP S5919117B2
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
group
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49037765A
Other languages
English (en)
Japanese (ja)
Other versions
JPS49128000A (hu
Inventor
ジヨセフ カリナン ジヨ−ジ
ジヤ−ゾン ケ−ト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS49128000A publication Critical patent/JPS49128000A/ja
Publication of JPS5919117B2 publication Critical patent/JPS5919117B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP49037765A 1973-04-02 1974-04-02 ビンブラスチン・ロイロシジンおよびロイロクリスチン誘導体の製法 Expired JPS5919117B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34727573A 1973-04-02 1973-04-02
US347275 1973-04-02

Publications (2)

Publication Number Publication Date
JPS49128000A JPS49128000A (hu) 1974-12-07
JPS5919117B2 true JPS5919117B2 (ja) 1984-05-02

Family

ID=23363051

Family Applications (2)

Application Number Title Priority Date Filing Date
JP49037765A Expired JPS5919117B2 (ja) 1973-04-02 1974-04-02 ビンブラスチン・ロイロシジンおよびロイロクリスチン誘導体の製法
JP58238722A Expired JPS6033837B2 (ja) 1973-04-02 1983-12-16 ビンブラスチン、ロイロシジンおよびロイロクリスチン誘導体製造原料の製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP58238722A Expired JPS6033837B2 (ja) 1973-04-02 1983-12-16 ビンブラスチン、ロイロシジンおよびロイロクリスチン誘導体製造原料の製法

Country Status (28)

Country Link
JP (2) JPS5919117B2 (hu)
AR (2) AR204004A1 (hu)
AT (1) AT340605B (hu)
BE (1) BE813168A (hu)
BG (3) BG21612A3 (hu)
CA (1) CA1042428A (hu)
CH (1) CH603669A5 (hu)
CS (1) CS185223B2 (hu)
CY (1) CY1044A (hu)
DD (1) DD113538A5 (hu)
DE (1) DE2415980A1 (hu)
DK (1) DK141511B (hu)
ES (2) ES424882A1 (hu)
FR (1) FR2223044B1 (hu)
GB (1) GB1463575A (hu)
HK (1) HK20180A (hu)
HU (1) HU171572B (hu)
IE (1) IE39071B1 (hu)
IL (1) IL44415A (hu)
KE (1) KE3028A (hu)
MY (1) MY8100025A (hu)
NL (1) NL181079C (hu)
PH (1) PH13623A (hu)
RO (2) RO77533A (hu)
SE (1) SE416206B (hu)
SU (4) SU731900A3 (hu)
YU (3) YU39719B (hu)
ZA (1) ZA741674B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (hu) * 1976-09-08 1982-07-07 Lilly Co Eli
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30560E (en) * 1976-12-06 1981-03-31 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
US4203898A (en) 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4199504A (en) * 1978-05-15 1980-04-22 Eli Lilly And Company Bridged cathranthus alkaloid dimers
US4357334A (en) 1980-03-20 1982-11-02 Eli Lilly And Company Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms
LU83822A1 (fr) 1981-12-08 1983-09-01 Omnichem Sa Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
FR2623504B1 (fr) * 1987-11-25 1990-03-09 Adir Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
HUT76925A (hu) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bisz-indol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
US20080161251A1 (en) 2005-01-21 2008-07-03 Astex Therapeutics Limited Pharmaceutical Compounds
CA2615374A1 (en) 2005-07-18 2007-01-25 Ernest Kun Kun Treatment of cancer
AU2007292306A1 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by PARP inhibitors and methods of treatment thereof
JP2010502730A (ja) 2006-09-05 2010-01-28 バイパー サイエンシズ,インコーポレイティド 癌の治療法
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
CN103169973A (zh) 2007-11-12 2013-06-26 彼帕科学公司 使用4-碘-3-硝基苯甲酰胺化合物与抗肿瘤剂组合治疗乳腺癌
CN105121447B (zh) * 2013-04-19 2018-02-02 暨南大学 长春碱类衍生物及其制备方法和应用
CN113456797B (zh) * 2021-06-18 2024-03-08 暨南大学 长春碱类衍生物在制备治疗骨肉瘤和/或软组织肉瘤药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine

Also Published As

Publication number Publication date
AR203882A1 (es) 1975-10-31
AU6671974A (en) 1975-09-18
YU39719B (en) 1985-04-30
IE39071L (en) 1974-10-02
DD113538A5 (hu) 1975-06-12
CS185223B2 (en) 1978-09-15
CA1042428A (en) 1978-11-14
ES446571A1 (es) 1977-06-16
YU81774A (en) 1982-05-31
HK20180A (en) 1980-04-25
YU39876B (en) 1985-04-30
AT340605B (de) 1977-12-27
HU171572B (hu) 1978-02-28
RO73524B (ro) 1984-11-30
GB1463575A (en) 1977-02-02
ES424882A1 (es) 1976-12-16
RO77533A (ro) 1982-02-01
DE2415980A1 (de) 1974-10-10
CH603669A5 (hu) 1978-08-31
JPS59193895A (ja) 1984-11-02
SU623522A3 (ru) 1978-09-05
AR204004A1 (es) 1975-11-12
BG22831A3 (bg) 1977-04-20
BE813168A (fr) 1974-10-02
YU39875B (en) 1985-04-30
PH13623A (en) 1980-08-07
RO73524A (ro) 1984-10-31
BG21235A3 (bg) 1976-03-20
IE39071B1 (en) 1978-08-02
JPS6033837B2 (ja) 1985-08-05
NL181079C (nl) 1987-06-16
NL181079B (nl) 1987-01-16
MY8100025A (en) 1981-12-31
YU113880A (en) 1982-05-31
JPS49128000A (hu) 1974-12-07
DE2415980C2 (hu) 1989-11-09
IL44415A (en) 1978-08-31
FR2223044B1 (hu) 1978-06-30
ZA741674B (en) 1975-10-29
KE3028A (en) 1980-03-28
DK141511B (da) 1980-04-08
SU784783A3 (ru) 1980-11-30
FR2223044A1 (hu) 1974-10-25
SE416206B (sv) 1980-12-08
SU731900A3 (ru) 1980-04-30
NL7404423A (hu) 1974-10-04
DK141511C (hu) 1980-09-29
CY1044A (en) 1980-08-01
IL44415A0 (en) 1974-06-30
SU652896A3 (ru) 1979-03-15
YU113980A (en) 1982-05-31
ATA267974A (de) 1977-04-15
BG21612A3 (bg) 1976-07-20

Similar Documents

Publication Publication Date Title
JPS5919117B2 (ja) ビンブラスチン・ロイロシジンおよびロイロクリスチン誘導体の製法
US4203898A (en) Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4166810A (en) Derivatives of 4-desacetyl VLB C-3 carboxyhydrazide
CA1067073A (en) Amide derivatives of vlb, leurosidine, leurocristine and related dimeric alkaloid
CA1082179A (en) Amide derivatives of vlb, leurosidine, leurocristine and related dimeric alkaloids
US4430347A (en) Cystamine derivatives suitable for use as medicaments
FR2517680A1 (fr) Derives n-(vinblastinoyl-23) d'acides amines, leur preparation et leur application therapeutique
HU180724B (en) Process for producing vinblastine-3-spiro-5-comma above-comma above-oxazolidine-2-comma above-comma above,4-comma above-comma above-dione
KR790000810B1 (ko) 빈브라스틴 유도체의 제조방법
AT345996B (de) Verfahren zur herstellung neuer amidderivate von vinblastin, leurosidin und leurocristin und ihrer saeureadditionssalze
KR810001453B1 (ko) 인돌-디하이드로인돌 카복스 아마이드 이량체의 제조방법
US4135048A (en) Anaphylactic inhibiting trans-octahydronaphto[1,2-c:5,6-c'] dipyrazoles
KR820001240B1 (ko) 4-데스 아세틸 vlb c-3카복스하이드라지드의 항종양 유도체 제조방법
US4167577A (en) Anaphylactic inhibitors
KR820001241B1 (ko) 4-데스아세틸 vlb c-3카복스하이드라지드의 항종양유도체 제조방법
US3225053A (en) Quebrachidine and derivatives
KR810000494B1 (ko) 빈카 알카로이드의 옥사졸리딘 디온 유도체의 제조방법
PL94203B1 (hu)
CA1127153A (en) Bridged catharanthus alkaloid dimers
KR830002079B1 (ko) 4'-데옥시 vlb "a"와 "b" 및 관련 1-포르밀 화합물의 3'-산화된 유도체의 제조방법
Dolzhenko et al. Substituted Amides and Hydrazides of Dicarboxylic Acids. Part 11.1 Synthesis and Pharmacological Activity of a Series of Pyridylamides of Dicarboxylic Acids
WO1996031518A1 (en) Novel tumor-inhibiting bisindole derivatives with calmodulin-liberator effect and pharmaceutical composition containing them
JPS6153360B2 (hu)
Anisimova et al. Research on imidazo [1, 2-a] benzimidazole derivatives: 19. Action of excess nitrous acid on 9-methyl-2-phenylimidazo [1, 2-a] benzimidazole
Anisimova et al. Research on imidazo [1, 2-a] benzimidazole derivatives